Study protocol for a controlled clinical trial on cardiac telerehabilitation and educational follow-up in patients with heart failure.

<h4>Background</h4>Heart failure is a primary non-communicable disease in Latin America and the Caribbean, which significantly reduces patients' quality of life. After diagnosis, emphasis is placed on cardiac rehabilitation and patient education regarding healthy lifestyles and habi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jhonatan Betancourt-Peña, Iago Portela-Pino, María José Martínez-Patiño
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0327366
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<h4>Background</h4>Heart failure is a primary non-communicable disease in Latin America and the Caribbean, which significantly reduces patients' quality of life. After diagnosis, emphasis is placed on cardiac rehabilitation and patient education regarding healthy lifestyles and habits. Interdisciplinary management is crucial in this process. However, lack of treatment adherence is a recurring issue in this population. In this context, technology allows us to address non-adherence to treatment. Its implementation helps overcome barriers and achieve treatment goals.<h4>Objective</h4>To determine the effects of a cardiac telerehabilitation-mediated exercise program and telephone educational follow-up on functional capacity in patients with heart failure, compared with cardiac telerehabilitation and conventional outpatient cardiac rehabilitation.<h4>Methods</h4>This article presents a SPIRIT-compliant protocol study of a three-arm, controlled, crossover clinical trial using participant blinding and simple sealed envelope block randomization.<h4>Conclusion</h4>According to the literature review, this can be considered the first three-arm clinical trial in the telerehabilitation of patients with heart failure. The measurement and intervention instruments are comparable and adequate compared to other studies.<h4>Trial registration</h4>ClinicalTrials.gov NCT05761639.
ISSN:1932-6203